Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.
about
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityProgress in HIV vaccine research.Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesProtection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoproteinCytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization.Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice.Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequenceHybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathwaySafety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.HIV/AIDS Vaccine Development: Challenges, Progress and Future Directions.Ramifications of HLA class I polymorphism and population genetics for vaccine development.
P2860
Q28749845-2CB7EC37-11CA-4BB1-923A-86478B491AF8Q30331429-485501B2-8F21-42AA-92DC-09A70BE0E6C6Q33639792-F33C8D04-0301-4F8B-B307-11B44DD35ABEQ33865376-9721DEB1-3821-48EC-AA4F-681C5FFAC5F1Q34357220-D7CE6A6C-6700-4DDB-A1B8-AC6E38318C16Q36361373-890B53FA-0416-4894-9E30-C5F7A6726B6DQ36478934-FF08439E-7841-421E-95DC-F5FB4625D960Q36597984-0EF58876-1554-4AC2-AA2E-5CFA30D9AAFEQ36647277-FBE43B3F-1032-4615-B244-86581E277AE8Q37170547-103D3B44-C5D6-4789-8BBE-B8EA830E63A8Q37216571-96548657-6704-4A2F-B48B-83A2C4831A63Q40041508-ADE0F24E-A8D7-4A08-AEA5-C33586D7163AQ40054175-A9B97708-9839-4FB3-AAA4-E247449F1C98Q40381395-39F0DA87-F5EB-42DF-97F8-5A538CF3D067Q40927003-2DEE2E86-010B-4472-BC89-3E2909AE1FF7Q52070060-B435919F-4BC0-4A18-A7D4-35157CD601D0
P2860
Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Priming of anti-human immunode ...... r-free HIV synthetic peptides.
@en
Priming of anti-human immunodeficiency virus
@nl
type
label
Priming of anti-human immunode ...... r-free HIV synthetic peptides.
@en
Priming of anti-human immunodeficiency virus
@nl
prefLabel
Priming of anti-human immunode ...... r-free HIV synthetic peptides.
@en
Priming of anti-human immunodeficiency virus
@nl
P2093
P2860
P356
P1476
Priming of anti-human immunode ...... r-free HIV synthetic peptides.
@en
P2093
E M Washburn
K J Weinhold
R M Scearce
T J Palker
P2860
P304
P356
10.1073/PNAS.88.21.9448
P407
P577
1991-11-01T00:00:00Z